Private Equity Co. Sees Red Over Purple's Poison Pill Plan
The largest stockholder of mattress and sleep products maker Purple Innovation Inc. has hit the company's directors with a three-count Delaware Chancery suit targeting an allegedly improper and unjustified adoption of...To view the full article, register now.
Already a subscriber? Click here to view full article